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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S126mineralization of OA Obwhich is also reduced compared to normal was
partially restored by HGF-siRNA treatment whereas the addition of HGF
to normal Ob reduced their mineralization.
Conclusions: OA Ob expressed more HGF than normal Ob. Increased
HGF stimulates the expression of TGF-b1 in OA Ob and reduces their
response to BMP-2. Inhibiting HGF expression or signaling restored the
response to BMP-2 and Smad 1/5/8 signaling. In addition, increased HGF
prevents the normal mineralization of OA Ob. In summary, this study
raises the hypothesis that increased HGF levels may be implicated in
the OA.224
HYPERTROPHIC DIFFERENTIATION DURING CHONDROGENIC
DIFFERENTIATION OF PROGENITOR CELLS IS STIMULATED BY BMP-
2 BUT SUPPRESSED BY BMP-7
M.M. Caron, P.J. Emans, M.M. Coolsen, D.A. Surtel, A. Cremers,
L.W. van Rhijn, T.J. Welting. Maastricht Univ. Med. Ctr., Maastricht, The
Netherlands
Purpose: Bone morphogenic protein (BMP)-2 and BMP-7 are clinically
approved and their recombinant proteins are used for bone tissue
regenerative purposes and widely evaluated in the context of cartilage
regeneration. A comparison of the in vitro chondrogenic characteris-
tics of BMP-2 versus BMP-7 on chondrogenic differentiation of
progenitor cells and potential differentially induced downstream
signalling has not been reported and was topic of investigation in this
study.
Methods: Equimolar concentrations of BMP-2 or BMP-7 were added to
chondrogenic differentiating ATDC5 or human bone marrow stem cells
and samples were harvested at appropriate time points in chondrogenic
differentiation. Expression of Col2a1, Sox9, Acan, Col10a1, Runx2, ALP,
Mmp13, Mef2c and Bapx1/Nkx3.2 was determined by RT-qPCR and
immunoblotting. Glycosaminoglycan (GAG) content and cell prolifera-
tion capacity were analysed by colorimetric analyses. The role of Bapx1/
Nkx3.2 during chondrogenic differentiation under BMP conditions was
investigated by targeting Bapx1/Nkx3.2 expression using a target
speciﬁc siRNA duplex.
Results: BMP-2 dose-dependently increased expression of chondrocyte
hypertrophic genes Col10a1, Runx2, ALP, Mef2c and Mmp13 during
chondrogenic differentiation of progenitor cells. In contrast, the pres-
ence of BMP-7 during chondrogenic differentiating of ATDC5 cells
resulted in decreased expression of chondrocyte hypertrophic genes
and an overall increased Col2a1, Acan and Sox9 expression. Both BMPs
did not inﬂuence the rate of cell proliferation, while both indistin-
guishably induced total GAG content. This profound differential action
of BMP-2 and BMP-7 on ATDC5 chondrogenic differentiation could also
be conﬁrmed in hBMSCs. In a candidate approach Bapx1/Nkx3.2 was
found to be involved in the BMP-7-mediated suppression of chon-
drocyte hypertrophy. As opposed to BMP-2, Bapx1/Nkx3.2 expression
was speciﬁcally increased in the BMP-7 conditions while knockdown of
Bapx1/Nkx3.2 expression abrogated the BMP-7-mediated hypertrophic
suppression.
Conclusion: BMP-2 and BMP-7 display opposing actions on the chon-
drogenic outcome of differentiating progenitor cells: BMP-2 acts
a speciﬁc inducer of chondrocyte hypertrophy, while BMP-7 appears to
increase or maintain chondrogenic potential and suppress chondrocyte
hypertrophy. Studies into the underlying mechanism revealed Bapx1/
Nkx3.2 as a potential transcriptional mediator in the BMP-7-induced
hypertrophic suppression. Based on these results we expect that
differential use of BMP-2 or BMP-7 will beneﬁt bone and cartilage
regenerative techniques by inducing or preventing chondrocyte hyper-
trophy, respectively.225
HYALURONAN INHIBITS NUCLEAR FACTOR-kB ACTIVATION BY TYPE
II COLLAGEN PEPTIDE IN OSTEOARTHRITIC CHONDROCYTES VIA
CD44 AND ICAM-1
T. Yasuda. Tenri Univ., Tenri, Japan
Background: In addition to the proinﬂammatory cytokines, there is an
increasing body of evidence that degradation products of cartilage
matrix are important ampliﬁers or catabolic players in diseased joints
like osteoarthritis (OA). Excessive degradation of cartilage matrix in
OA involves enhanced cleavage of type II collagen by collagenases,especially matrix metalloproteinase (MMP)-13, resulting in denatur-
ation of the triple helix of this collagen. Denatured and degraded type
II collagen leads to an increase in proteolytic products of type II
collagen. Recently, we have found that a 24-mer synthetic peptide of
type II collagen named CB12-II stimulates type II collagen cleavage
with induction of MMP-13 in cartilage explant culture. Although the
intracellular signaling that leads to cartilage destruction is mediated
by a cluster of catabolic pathways including nuclear factor-kB (NF-kB),
the effect of CB12-II on NF-kB remains unclear. Hyaluronan (HA) of
high molecular weight is widely used in the treatment of OA by intra-
articular injection. An increasing body of evidence indicates that HA
suppresses catabolic actions by proinﬂammatory cytokines like
interleukin-1 and matrikines such as ﬁbronectin fragments. However,
little is known of HA effect on actions of CB12-II through interaction
with HA receptors such as CD44 and intercellular adhesion molecule-1
(ICAM-1).
Purpose: This study was aimed to examine NF-kB activation in asso-
ciation with MMP-13 production by CB12-II and its inhibition by HA via
its receptors, CD44 and ICAM-1 in OA chondrocytes.
Methods: With or without pretreatment with either 2700 kDa HA or
BAY11-7085, cartilage explants harvested from OA knee joints or iso-
lated chondrocytes in monolayer were incubated with CB12-II or the
scramble peptide. In another set of experiments, following pre-
incubation with anti-ICAM-1, anti-CD44, a combination of both anti-
bodies, or non-speciﬁc IgG, cartilage explants harvested from OA knee
joints or isolated chondrocytes in monolayer were incubated with or
without 2700 kDa HA, followed by coincubation with CB12-II. Control
cultures had no additives.
Enzyme-linked immunosorbent assays for phosphorylated p65 NF-kB
and MMP13 were performed using total cell lysates and culture
supernatants, respectively.
Results: When cartilage explants or chondrocytes in monolayer were
incubated with CB12-II, the type II collagen peptide activated NF-kB in
association with enhanced MMP-13 production. Inhibition studies with
the speciﬁc inhibitor indicated the requirement of NF-kB for CB12-II-
induced MMP-13 production. Pretreatment with HA resulted in signif-
icant suppression of CB12-II-stimulated MMP-13 production in carti-
lage as well as in chondrocyte monolayer cultures. HA suppressed NF-
kB activation by CB12-II, leading to a decrease in MMP-13 production.
While the individual antibody to CD44 or ICAM-1 partially reversed HA
effect on CB12-II action, both antibodies in combination completely
blocked the HA effect.
Conclusions: Administration of HA into osteoarthritic joints could
suppress the catabolic action of matrix degradation products like CB12-
II as a potent NF-kB inhibitor. The present study clearly demonstrated
that HA suppressed CB12-II-activated NF-kB via CD44 and ICAM-1 in OA
articular chondrocytes, leading to decreased MMP-13 production.
Administration of HA into osteoarthritic joints could suppress the
catabolic action of matrix degradation products like type II collagen
fragments in OA joints through the mechanism demonstrated in this
study.226
PROSTAGLANDINS AND CYCLOOXYGENASES IN CHONDROGENIC
DIFFERENTIATION OF PROGENITOR CELLS
M.M. Caron, P.J. Emans, D.A. Surtel, A. Cremers, D. Ophelders,
K. Sanen, L.W. van Rhijn, T.J. Welting. Maastricht Univ. Med. Ctr.,
Maastricht, The Netherlands
Purpose: Prostaglandins (PGs) and their synthesizing enzymes
Cyclooxygenase (COX)-1 and -2 are key factors in inﬂammatory
processes, as well as in the biology of osteocytes and osteoclasts.
Although known to be involved in the biology of the bony part of the
skeleton, an involvement of PGs and COX-enzymes in the cartilagi-
nous skeletal compartment is poorly addressed. To investigate the
relation between chondrogenic differentiation, PGs and COX-enzymes
we hypothesized that COX-1 and COX-2 have differential actions in
the chondrogenic differentiation process of progenitor cells and that
speciﬁc inhibition of their enzymatic activity leads to isotype-speciﬁc
consequences on the outcome of the chondrogenic differentiation
process.
Methods: ATDC5 cells were differentiated in the presence of different
COX-1 (SC-560, Mofezolac) or COX-2 (NS398, Celecoxib) speciﬁc non-
steroidal anti-inﬂammatory drugs (NSAIDs). COX-1 or COX-2 speciﬁcity
of the NSAIDs and prostaglandin levels were determined by
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S127colorimetric activity assays and speciﬁc ELISAs. PGE2, PGD2, PGF2a or
TXA2 were added during the differentiation process. Gene- and protein
expression analyses were employed to determine the chondrogenic
consequences.
Results: COX-speciﬁcity of the NSAIDs was conﬁrmed and for subse-
quent experiments NSAID concentrations were selected that resulted
in similar degrees of COX-1 or COX-2 inhibition. Inhibition of COX-1
impaired the expression of Col2a1 and Col10a1, whereas inhibition of
COX-2 speciﬁcally decreased Col10a1 expression. To ﬁnd an explana-
tion for this difference we determined the expression patterns of both
COX enzymes as well as excretion of speciﬁc prostaglandins during
differentiation. COX-1 expression is speciﬁcally upregulated during
late chondrogenic differentiation (after 10 days), whereas COX-2
expression is brieﬂy upregulated early in differentiation (ﬁrst 24
hours) and increases again late in differentiation. PGD2 and PGE2
concentrations in the culture supernatant followed the COX-2
expression pattern, whereas PGF2a and TXA2 levels remained stably
low. Inhibition of COX-2 resulted in decreased levels of all measured
PGs, while COX-1 inhibition decreased the concentration of PGE2 and
TXA2, but increased PGD2 and PGF2a levels. Addition of PGE2 or
PGF2a increased expression of chondrogenic genes in general,
whereas TXA2 speciﬁcally stimulated expression of hypertrophic
markers.
Conclusions: Our ﬁndings point towards a differential role for COX-
enzymes and speciﬁc PGs in chondrogenic differentiation. As our
results provide novel insight into a previously underexposed area of
interest, they may open new doors and provide novel targets for
improving collagen quality of cartilage constructs in regenerative
approaches.Figure 1. Ă227
THE ROLES OF HEAT SHOCK PROTEIN 70 ON CHONDROCYTE
T. Matsuki y, Y. Arai y, S. Tsuchida y, R. Terauchi y, H. Inoue y,
S. Nakagawa y,z, A. Inoue y, O. Mazda x, T. Kubo y. yDept. of
Orthopaedics, Graduate Sch. of Med. Sci., Kyoto Prefectural Univ. of Med.,
Kyoto, Japan; zDept. of Rheumatic Diseases and Joint Function, Kyoto
Prefectural Univ. of Med., Kyoto, Japan, Kyoto, Japan; xDept. of
Immunology, Kyoto Prefectural Univ. of Med., Kyoto, Japan
Purpose: The role of oxygen as an important modulator of gene
expression is well recognized and extensive evidence implicates
hypoxia-inducible factor (HIF) as the primary gene regulatory factor
that responds to variations in O2 levels. The transcription factor HIF-1
alpha (HIF-1a) represents one important element inmaintaining proper
cellular functions under hypoxia. HIF-1a is essential for chondrogenesis,
such as chondrocyte growth arrest, survival, maturation, and apoptosis.
On the other hand, we have reported that heat shock protein 70 (HSP70)
which is a molecular chaperone has stress response mechanisms, such
as enhancing effects of matrix metabolism, and protective effects in
articular cartilage. The aim of this study is to reveal the roles of HSP70
on cultured chondrocytes exposed to hypoxic condition or nitric oxide
(NO) induced apoptosis.
Methods: The primary chondrocytes isolated from Japanese white
rabbits were cultured for 24 hours in the regular oxygen environment
of 20%(normoxia) of oxygen, and 1%(hypoxia) of low oxygen. Pre-
designed siRNAs targeting rabbit HIF-1a(si-HIF-1a) and HSP70(si-
HSP70) were used. CoCl2, a chemical inducer of HIF-1, was added to
the cells incubated under normoxia as a pseudo hypoxia. The mRNA
levels of HIF-1a and HSP70 were measured by quantitative real-time
reverse transcription polymerase chain reaction (RT-PCR). The protein
production was subjected to Western blotting for HIF-1a and HSP70.
Apoptosis was induced by 0.5 mM sodium nitroprusside (SNP)
dehydrate that produces NO. Cell viability was assessed by lactate
dehydrogenase (LDH) release and tetrazolium salt-based assays.
Statistical signiﬁcance was deﬁned as a p-value of less than 0.05 by
Tukey's test.
Results: Under hypoxia and pseudo hypoxia, the expression levels of
HIF-1a and HSP70 were signiﬁcantly increased. si-HIF-1a inhibited
the expression levels of HSP70, although si-HSP70 did not suppress
the expression levels of HIF-1a. The cell viability was positively
correlated with hypoxia. Transfection with si-HIF-1a or si-HSP70
canceled the protective effects of hypoxia. LDH release from the SNP-
treated cells was suppressed under hypoxia. The LDH release was
almost completely blocked by transfection with si-HIF-1a or si-HSP70
(Figure 1).Conclusions: Although HIF-1a gene expression was not suppressed by
si-HSP70 transfection, the expression levels of HSP70 and HIF-1a were
suppressed by si-HIF-1a transfection. This shows that HSP70 might, at
least partially, be regulated by HIF-1a in articular chondrocyte. In this
meeting last year, we showed that the expression of extracellular
matrix gene was stimulated by HSP70 enhanced under hypoxia in
chondrocyte. These indicate that HIF-1a may regulate extracellular
matrix synthesis in chondrocytes via HSP70, which may lead to chon-
droprotective function under hypoxia. In this study, chondrocytes under
hypoxic condition were protected from NO-induced apoptosis. Sup-
pressing expression levels of HIF-1a or HSP70 under hypoxia showed an
acceleration of the NO-induced apoptosis in chondrocyte. These suggest
that HIF-1a and HSP70 pathway under hypoxia may essentially
participated in the inhibition of cytotoxicity triggered by stresses as
“cartilage homeostasis program”. Regulation of HIF-1a and HSP70
expression may provide a novel therapeutic strategy for OA.228
INTERLEUKIN 1 INDUCES AGGRECAN DEGRADATION BY HUMAN
ARTICULAR CHONDROCYTES THROUGH A TAK1/MKK4/JNK2
PATHWAY WITHOUT INVOLVEMENT OF NFKB
H.M. Ismail, Y. Sawaji, J. Saklatvala;. Kennedy Inst. of Rheumatology,
NDORMS, Univ. of Oxford., London, United Kingdom
Aggrecan is the main proteoglycan in the articular cartilage, providing
this tissue with the ability of load bearing and the resistance to
compression. Loss of aggrecan occurs in rheumatoid and osteoarthritis
and can be induced by inﬂammatory cytokines such as IL1 and TNF. In
vitro, IL1 can be shown to induce cartilage degradation through
induction of speciﬁc aggrecan cleavages characteristic of ADAMTS
enzymes. ADAMTS 4 and 5 are the best characterized aggrecanases and
in mice knockout of the ADAMTS-5 gene is chondroprotective in
experimental arthritis. It is not known which aggrecanases are impor-
tant in human cartilage, nor which signal transduction pathways
mediate the effect of IL1. Free aggrecanase activity can never be
detected in IL1 stimulated cartilage cultures and the chondrocytes
embedded in tissues cannot be transfected. Here we aimed to dissect
the signalling pathways involved in IL1-induced cartilage degradation
by human chondrocytes using a cell based assay. This assay helped us to
combine siRNA based knockdown with aggrecan degradation assays.
Using this strategy, we show that ADAMTS5 is the main aggrecanase in
human chondrocytes that regulate aggrecan degradation. We identiﬁed
an essential role of TRAF6/TAK1 signalling axis in this degradative
mechanism. Furthermore, we report that TAK1 regulates aggrecan
degradation through MKK4/JNK2 as the main downstream players.
Interestingly, we found that NFkB is not essential for IL1- induced
aggrecan degradation. Those results highlight a signiﬁcant role of
MKK4/JNK2 signalling pathway in cartilage degradationwhich could be
a useful therapeutic target in osteoarthritis.
